刘佳佳,马文宇

本维莫德（benvitimod）是一种芪类小分子化合物，通过激活芳烃受体发挥抗氧化、免疫平衡调节、促进皮肤屏障修复、减少水分流失等作用治疗银屑病和特应性皮炎。2019年被我国药品监督管理局批准用于局部治疗成人轻中度寻常型银屑病，临床疗效较好。随后发现其在特应性皮炎豚鼠的治疗中效果良好，可予以临床推广。本维莫德安全性良好，患者耐受度好，常见的不良反应为瘙痒、毛囊炎、接触性皮炎、色素异常、皮炎和皮肤干燥。

本维莫德；银屑病；特应性皮炎；免疫平衡调节；芳基烃

[1] Thomas G M,Poinar G O.Xenorhabdus gen.nov.a Genus of Entomopathogenic,Nematophilic Bacteria of the Family Enterobacteriaceae [J].International Journal of Systematic Bacteriology,1979,29(4):352-360. [2] Khan A,Brooks W M.A Chromogenic Bioluminescent Bacterium Associated with the Entomophilic Nematode Chromonema heliothidis1[J].Journal of Invertebrate Pathology,1977,29(3):253-261. [3] Poinar G,Thomas G,Hess R.Characteristics of the specific bacterium associated with Heterorhabditis bacteriophora.1977. [4] Poinar GO,Thomas G,Haygood M,Nealson KH.Growth and luminescence of the symbolic bacteria associated with the terrestrial nematode,Heterorphabditis bacteriophora[J].Soil Biology and Biochemistry.1980;12:5-10. [5] Stock SP,Kusakabe A,Orozco RA.Secondary Metabolites Produced by Heterorhabditis Symbionts and Their Application in Agriculture:What We Know and What to Do Next[J].J Nematol.2017;49:373-383. [6] Poinar GO,Jr.,Thomas GM.Significance of Achromobacter nematophilus Poinar and Thomas(Achromobacteraceae:Eubacteriales)in the development of the nematode,DD-136(Neoaplectana sp.Steinernematidae)[J].Parasitology.1966;56:385-390. [7] Dutky SR.Insect microbiology[J].Adv Appl Microbiol.1959;1:175-200. [8] Paul V J,Frautschy S,Fenical W,et al.Antibiotics in microbial ecology:Isolation and structure assignment of several new antibacterial compounds from the insectsymbiotic bacteriaXenorhabdus spp[J].Journal of Chemical Ecology,1981,7(3):589- [9] Li J,Chen G H,Wu H M,et al.Identification of two pigments and a hydroxystilbene antibiotic from Photorhabdus luminescens.[J].Appl Environ Microbiol,1995,61(12):4329-4333 [10] Susan,H,Smith,et al.Tapinarof Is a Natural AhR Agonist that Resolves Skin Inflammation in Mice and Humans.[J].Journal of Investigative Dermatology,2017.137(10):2110-2119 [11] Furue M,Tsuji G,Mitoma C,Nakahara T,Chiba T,Morino-Koga S,et al.Gene regulation of filaggrin and other skin barrier proteins via aryl hydrocarbon receptor[J].J Dermatol Sci 2015;80:83e8. [12] Psomadakis C E,Han G.New and Emerging Topical Therapies for Psoriasis and Atopic Dermatitis[J].J Clin Aesthet Dermatol, 2019,12(12):28-34. [13] Liu X,Zhang X,Zhang J,et al.Activation of aryl hydrocarbon receptor in Langerhans cells by a microbial metabolite of tryptophan negatively regulates skin inflammation[J].J Dermatol Sci,2020,100(3):192-200. [14] Roztocil E,Hammond C L,Gonzalez M O,et al.The aryl hydrocarbon receptor pathway controls matrix metalloproteinase-1 and collagen levels in human orbitalfibroblasts[J].Sci Rep,2020,10(1):8477. [15] Kim J,Park S H,Yang S,et al.Protective Effects of Maclurin against Benzo[a]pyrene [16] Wang X,Li S,Liu L,et al.Role of the aryl hydrocarbon receptor signaling pathway in promoting mitochondrial biogenesis against oxidative damage in human melanocytes[J].J Dermatol Sci,2019,96(1):33-41. [17] Ogawa T,Ishitsuka Y.The Role of KEAP1-NRF2 System in Atopic Dermatitis and Psoriasis[J].Antioxidants(Basel),2022,11(7). [18] 胡宇晴,刘萍,慕彰磊,等.本维莫德对HaCaT细胞增殖､炎症因子分泌及皮肤屏障因子产生的影响[J].中华皮肤科杂志, 2020,53(12):984-991. [19] R Bissonnette,L Stein Gold,DS Rubenstein,et al.Tapinarof in the treatment of psoriasis:A review of the unique mechanism of action of a novel therapeutic aryl hydrocarbon receptormodulating agent[J].J Am Acad Dermatol,2021,84(4):1059-1067. [20] MERK H F.The aryl hydrocarbon receptor as the target struc-ture for new drugs in psoriasis and atopic dermatitis[J]. Hautarzt,2019, 70(12):942-947. [21] HU Y Q,LIU P,MU Z L,et al.Aryl hydrocarbon receptor ex-pression in serum,peripheral blood mononuclear cells,and skin lesions of patients with atopic dermatitis and its correlation with disease severity[J].Chin Med J(Engl),2020,133(2):148-153. [22] 马春辉,王宝庭.本维莫德乳膏治疗银屑病的研究进展[J].临床医学进展,2022,12(4):3416-3420. [23] Cai,L.;Chen,G.H.;Lu,Q.J.;et al.A double-blind,randomized,placebo-and positive-controlled phase III trial of 1%benvitimod cream in mild-to-moderate plaque psoriasis.Chin.Med.J.(Engl)2020,133,2905–2909. [24] Smith J,Cline A,Feldman SR.Advances in psoriasis.[J].South Med J,2017,110(1):65-75 [25] 张伟晴,沙日耐,姜萱璟,等.银屑病免疫治疗靶点研究进展[J].基因组学与应用生物学,2021,40(Z4):3853-3862 [26] Rodriguez BK,Tollefson M.Tapinarof to treat psoriasis[J].Drugs Today(Barc),2020,56(8):515-530 [27] Zhenlai Z,Jiaoling C,Yiting L,et al.Aryl hydrocarbon receptor in cutaneous vascular endothelial cells restricts psoriasis development by negatively regulating neutrophil recruitment[J].J Invest Dermatol,2020,140(6):1233-1243 [28] Lu ST,Kelly KA,Feldman SR.An overview of benvitimod for the treatment of psoriasis:a narrative review[J].Expert Opin Pharmacother,2021,23(3):327-333 [29] 李祥,张宝兰,张理涛.苯烯莫德对银屑病的治疗研究[J].中国中西医结合皮肤性病学杂志,2017,16(06):557-559 [30] 徐萱.消疕方联合NB-UVB治疗寻常型银屑病的临床疗效及对氧化应激和微炎症状态的影响[J].四川中医,2020,38(06):174-178 [31] 胡宇晴,刘萍,慕彰磊,等.本维莫德对HaCaT细胞增殖､炎症因子分泌及皮肤屏障因子产生的影响[J].中华皮肤科杂志, 2020,53(12):984-991 [32] Peppers,J.;Paller,A.S.;Maeda-Chubachi,T.;et al.randomized dose-finding study of tapinarof(GSK2894512 cream)for the treatment of atopic dermatitis.J.Am.Acad.Dermatol.2019,80,89–98.e3. [33] Kawasaki,H.,Nagao,K.,Kubo,A.,Hata,T.,Shimizu,A.,Amagai,M.(2012).Altered stratum corneum barrier and enhanced percutaneous immune responses in filaggrinnull mice[J].Journal of Allergy and Clinical Immunology,129,1538–1546.e6.e1536. [34] Lampe,M.A.,Burlingame,A.,Whitney,J.,Williams,M.L.,Brown,B.E.,Roitman,E.,&Elias,P.M.(1983).Human stratum corneum lipids:Characterization and regional variations[J].Journal of Lipid Research,24,120–130. [35] Imokawa,G.,Abe,A.,Jin,K.,Higaki,Y.,Kawashima,M.,&Hidano,A.(1991).Decreased level of ceramides in stratum corneum of atopic dermatitis:An etiologic factor in atopic dry skin[J].Journal of Investigative Dermatology,96,523–526. [36] Nakajima,K.,Terao,M.,Takaishi,M.,Kataoka,S.,Goto-Inoue,N.,Setou,M.,Azukizawa,H.(2013).Barrier abnormality due to ceramide deficiency leads to psoriasiform inflammation in a mouse model[J].Journal of Investigative Dermatology,133,2555–2565. [37] Tay,S.S.,Roediger,B.,Tong,P.L.,Tikoo,S.,&Weninger,W.(2014).The skinresident immune network[J].Current Dermatology Reports,3,13-22. [38] Weninger,W.,Biro,M.,&Jain,R.(2014).Leukocyte migration in the interstitial space of non-lymphoid organs[J].Nature Reviews Immunology,14,232–246. [39] Beck,L.A.,Thaci,D.,Hamilton,J.D.,Graham,N.M.,Bieber,T.,Rocklin,R.,Radin,A.R.(2014).Dupilumab treatment in adults with moderate -to-severe atopicdermatitis[J].New England Journal of Medicine,371,130–139. [40] Toshitani A,Ansel JC,Chan SC,Li SH,Hanifin JM.Increased interleukin 6 production by T cells derived from patients with atopic dermatitis[J].J Invest Dermatol 1993;100:299-304. [41] Lee CE,Neuland ME,Teaford HG,Villacis BF,Dixon PS,Valtier S,et al.Interleukin-6 is released in the cutaneous response to allergen challenge in atopic individuals[J].J Allergy Clin Immunol 1992;89:1010-20. [42] Yokoyama A,Kohno N,Sakai K,Kondo K,Hirasawa Y,Hiwada K.Circulating levels of soluble interleukin-6 receptor in patients with bronchial asthma[J].Am J Respir Crit Care Med 1997;156:1688-91. [43] Toshitani A,Ansel JC,Chan SC,Li SH,Hanifin JM.Increased interleukin 6 production by T cells derived from patients with atopic dermatitis[J].J Invest Dermatol 1993;100:299-304. [44] 徐灿.本维莫德对豚鼠特应性皮炎模型的影响及作用机制研究[D].郑州大学,2022. [45] Hiroyuki Kanoh,Asako Ishitsuka,et al.IFN-γReduces Epidermal Barrier Function by Affecting Fatty Acid Composition of Ceramide in a Mouse Atopic Dermatitis Model[J].Journal of Immunology Research.2019:1-10 [46] 闫军.治疗寻常型银屑病新药:本维莫德[J].中国新药与临床杂志,2023,42(01):14-17.

点击下载PDF